EGF THERAMED HEALTH CORP. Market Cap ($251.25K)
Market Cap & Net Worth: EGF THERAMED HEALTH CORP. (AUH)
EGF THERAMED HEALTH CORP. market cap. EGF THERAMED HEALTH CORP. (F:AUH) has a market capitalization of $251.25K (€214.91K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31307 globally and #2771 in its home market, demonstrating a -37.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EGF THERAMED HEALTH CORP.'s stock price €0.02 by its total outstanding shares 11616665 (11.62 Million).
EGF THERAMED HEALTH CORP. Market Cap History (2018–2026)
EGF THERAMED HEALTH CORP. market cap history from 2018 to 2026. Data shows change from $1.60 Billion to $251.25K (-71.24% CAGR). Check EGF THERAMED HEALTH CORP. (AUH) share price today for real-time trading data and today's change.
EGF THERAMED HEALTH CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EGF THERAMED HEALTH CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AUH by Market Capitalization
Companies near EGF THERAMED HEALTH CORP. in the global market cap rankings as of November 3, 2026.
Key companies related to EGF THERAMED HEALTH CORP. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #717 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1658 globally with a market cap of $14.29 Billion USD ( AU$20.19 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2014 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #717 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $307.00 |
| #1658 | Pro Medicus Ltd | AU:PME | $14.29 Billion | AU$193.27 |
| #2014 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $78.48 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.26 |
Market Capitalization of EGF THERAMED HEALTH CORP. (2018–2026)
Market capitalization of EGF THERAMED HEALTH CORP. from 2018 to today. Between 2018 and today, EGF THERAMED HEALTH CORP.'s market cap moved from $1.60 Billion to $ 251.25K, with a yearly change of -71.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €251.25K | -7.50% |
| 2025 | €271.62K | -79.30% |
| 2024 | €1.31 Million | -34.73% |
| 2023 | €2.01 Million | -40.80% |
| 2022 | €3.40 Million | -15.54% |
| 2021 | €4.02 Million | -75.33% |
| 2020 | €16.30 Million | -89.74% |
| 2019 | €158.90 Million | -90.08% |
| 2018 | €1.60 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of EGF THERAMED HEALTH CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $251.25K USD |
| MoneyControl | $251.25K USD |
| MarketWatch | $251.25K USD |
| marketcap.company | $251.25K USD |
| Reuters | $251.25K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EGF THERAMED HEALTH CORP.
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart dis… Read more